Synergistic Target‐Attacking Tumor Cells and M2 Macrophages via a Triple‐Responsive Nanoassembly for Complete Metastasis Blocking

Bei Wang,Hao Cheng,Zhongsheng Ji,Zijun Jiang,Rong Wang,Yang Ding,Jiang Ni
DOI: https://doi.org/10.1002/adhm.202304096
IF: 10
2024-12-13
Advanced Healthcare Materials
Abstract:Dual‐targeting and multi‐responsive nanoparticles are fabricated to simultaneously attack tumor cells and M2 TAMs for anti‐metastasis on epithelial mesenchymal transition (EMT). Synergy of RNA interference, chemotherapy, and photothermal treatment holds back the Snail‐enhancing transforming growth factor (TGF)‐β signal path via elimination of M2 TAMs, which collaborates with Snail silencing in tumor cells to reverse EMT biomarkers and metastasis‐promoting niche. Collaboration of cancerous cells and microenvironment is the root for tumor spreading, leading to difficulty in complete metastasis blockage via mono‐intervention. Herein, a triple‐responsive nanoassembly is designed for orienting tumor cells and migration‐driving M2 tumor associated macrophages (TAMs) in microenvironment for efficient anti‐metastatic therapy. Structurally, a reactive oxygen species (ROS)‐responsive crosslinked short‐chain polyquaternium is synthesized to bridge graphene oxide (GO) scaffold with apolipoprotein A‐I crown via borate‐crosslinking, electrostatic adherence, and coordinative coupling. The protein‐crowning polymeric GO nanoparticles could give multimodal shielding and triple‐responsive release of doxorubicin and Snail‐targeted siRNA. Tailor‐made apolipoprotein A‐I crown fulfills nanoparticles synergistically attacking tumor cells and M2 TAMs via binding with overexpressed scavenger receptors. The findings witness the targeted accumulation and potent cytotoxicity of the hybrid nanoparticles for M2 TAMs and tumor cells; especially, elimination of M2 TAMs in tumor microenvironment holds back Snail‐enhancing transforming growth factor (TGF)‐β signal pathway, which collaborates with Snail silencing in tumor cells to reverse epithelial mesenchymal transition (EMT) and metastasis‐promoting niche. Collectively, the synergistic targeting therapeutic platform could provide a promising solution for metastatic tumor treatment.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?